Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Node

Showing results (281-290 of 717) with videos related to

Pageof 72
Sort By:
The American Journal of the Medical Sciences|June 16, 2007
Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney diseaseTsukasa Nakamura, Takeshi Sugaya, Yasuhiro Kawagoe, et al.
Journal of Cardiovascular Pharmacology|April 18, 2023
Relationship Between Canagliflozin, Sodium Glucose Cotransporter 2 Inhibitor, and Hematopoietic Effects in Patients With Diabetes and Mild Heart Failure: Results From the CANDLE TrialDaisaku Nakatani, Tomoharu Dohi, Shungo Hikoso, et al.
Cardiovascular Diabetology|June 15, 2020
Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trialAtsushi Tanaka, Michio Shimabukuro, Yosuke Okada, et al.
ESC Heart Failure|October 6, 2021
Prognostic impact of follow-up serum albumin after acute myocardial infarctionGoro Yoshioka, Atsushi Tanaka, Kensaku Nishihira, et al.
International Journal of Cardiology|April 29, 2014
Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: PROLOGUE studyJun-Ichi Oyama, Tomoko Ishizu, Yasunori Sato, et al.
International Journal of Cardiology|April 1, 2014
Risk markers for coronary plaque progression and destabilization beyond LDL-cholesterol in acute coronary syndromeIsao Taguchi, Satoshi Koizumi, Michiya Kageyama, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 5, 2015
Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart diseaseRyo Noguchi, Koichi Nakayama, Manabu Itoh, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 12, 2020
Effect of rivaroxaban on urinary albumin excretion in patients with atrial fibrillation and chronic kidney disease: a randomized trial (X-NOAC)Atsushi Tanaka, Makoto Suzuki, Kazuo Matsunaga, et al.
Journal of Cardiology|July 5, 2016
EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in miceJun-Ichi Oyama, Aya Shiraki, Toshiyuki Nishikido, et al.
Scientific Reports|May 16, 2020
Bright light improves sleep in patients with Parkinson's disease: possible role of circadian restorationTakuyuki Endo, Ritsuko Matsumura, Isao T Tokuda, et al.
Pageof 72

Showing results (281-290 of 717) with videos related to

Sort By:
Pageof 72
The American Journal of the Medical Sciences|June 16, 2007
Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney diseaseTsukasa Nakamura, Takeshi Sugaya, Yasuhiro Kawagoe, et al.
Journal of Cardiovascular Pharmacology|April 18, 2023
Relationship Between Canagliflozin, Sodium Glucose Cotransporter 2 Inhibitor, and Hematopoietic Effects in Patients With Diabetes and Mild Heart Failure: Results From the CANDLE TrialDaisaku Nakatani, Tomoharu Dohi, Shungo Hikoso, et al.
Cardiovascular Diabetology|June 15, 2020
Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trialAtsushi Tanaka, Michio Shimabukuro, Yosuke Okada, et al.
ESC Heart Failure|October 6, 2021
Prognostic impact of follow-up serum albumin after acute myocardial infarctionGoro Yoshioka, Atsushi Tanaka, Kensaku Nishihira, et al.
International Journal of Cardiology|April 29, 2014
Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: PROLOGUE studyJun-Ichi Oyama, Tomoko Ishizu, Yasunori Sato, et al.
International Journal of Cardiology|April 1, 2014
Risk markers for coronary plaque progression and destabilization beyond LDL-cholesterol in acute coronary syndromeIsao Taguchi, Satoshi Koizumi, Michiya Kageyama, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 5, 2015
Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart diseaseRyo Noguchi, Koichi Nakayama, Manabu Itoh, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 12, 2020
Effect of rivaroxaban on urinary albumin excretion in patients with atrial fibrillation and chronic kidney disease: a randomized trial (X-NOAC)Atsushi Tanaka, Makoto Suzuki, Kazuo Matsunaga, et al.
Journal of Cardiology|July 5, 2016
EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in miceJun-Ichi Oyama, Aya Shiraki, Toshiyuki Nishikido, et al.
Scientific Reports|May 16, 2020
Bright light improves sleep in patients with Parkinson's disease: possible role of circadian restorationTakuyuki Endo, Ritsuko Matsumura, Isao T Tokuda, et al.
Pageof 72